Liver health is suddenly having a moment—and honestly, it’s about time. For years, people only really thought about their ...

Meghan McCain, the former co-host of “The View,” made headlines when she posted to social media recently in support of a ...

The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for certain approvals. FDA Commissioner Marty Makary, M.D., and Center for Biologics ...

May 19, 2025 – The FDA has approved the Novavax COVID-19 vaccine, a protein-based alternative to mRNA shots, with some limits on who can get it. The vaccine, called Nuvaxovid, is mainly ...

COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 that clinical trials will be required to approve annual COVID-19 ...

The FDA plans to limit COVID-19 vaccine booster recommendations to those over 65 or with underlying health conditions. FDA officials question the necessity of annual boosters for healthy ...

You can reach Usha on Signal at usha.22. A new framework for Covid-19 vaccines announced by Food and Drug Administration leaders Tuesday suggests the agency will no longer approve new Covid ...

U.S. Health and Human Services Sec. Robert F. Kennedy Jr. announced Tuesday that the COVID-19 vaccine will no longer be among the recommended vaccines for pregnant women and healthy children on ...

Health and Human Services Secretary Robert F. Kennedy Jr. said Tuesday that his agency would no longer recommend the coronavirus vaccine for healthy pregnant women and healthy children — an ...

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it. It's not a replacement for the company’s existing shot, but a second option.Video above ...

Healthy Americans under 65 who want an annual COVID vaccine will be out of luck under a new Food and Drug Administration policy unveiled Tuesday. Under the plan, the FDA will allow seniors and ...

Taking away vaccines from people who might benefit: not so much. This week, two new leaders at the US Food and Drug Administration announced plans to limit access to covid vaccines, arguing that ...